Spry1 promotes the tumorigenic capacities of rhabdomyosarcoma [31], while this member of the Spry protein family exerts tumor-suppressive roles in cancers of the prostate [32] and thyroid [33]. The gene discussed is SPRY1; the disease is rhabdomyosarcoma.